Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5772665

O=C(CCc1cnoc1-c1ccc(C(F)(F)F)cc1)Nc1cccnc1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
KLF5 Q13887 1/20 0.52
NOTUM Q6P988 1/20 0.47
LMNA P02545 4/20 0.46
EPHX2 P34913 3/20 0.44
PKM P14618 3/20 0.44
ALDH1A1 P00352 1/20 0.44
USP2 O75604 1/20 0.44
POLB P06746 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
HDAC4 P56524 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5771101 0.90 TP53 (0.46) NPC1RAB9AKLF5LMNAALDH1A1
SCHEMBL5773606 0.88 MAPT (0.48) NPC1RAB9AKLF5LMNAALDH1A1
Trifluoroacetic Acid SCHEMBL5774473 0.85 CYP3A4 (0.52) LMNAALDH1A1SMN1; SMN2HTTMAPT
Trifluoroacetic Acid SCHEMBL5773866 0.84 ALDH1A1 (0.48) LMNAALDH1A1SMN1; SMN2HTTTP53
Trifluoroacetic Acid SCHEMBL5776422 0.83 MCHR1 (0.46) NPC1ALDH1A1POLBSMN1; SMN2HDAC4
SCHEMBL5774865 0.83 LMNA (0.61) NPC1RAB9AKLF5NOTUMLMNA
SCHEMBL5774003 0.83 MGLL (0.50) LMNAALDH1A1SMN1; SMN2HDAC4HDAC6
Trifluoroacetic Acid SCHEMBL5771064 0.82 LMNA (0.44) NPC1RAB9AKLF5LMNASMN1; SMN2
Trifluoroacetic Acid SCHEMBL5775554 0.82 HDAC4 (0.43) EPHX2ALDH1A1SMN1; SMN2HDAC4HDAC6
SCHEMBL5775672 0.82 MAPT (0.50) NPC1RAB9ALMNAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR NPC1 2417/4885RAB9A 3076/4885KLF5 3753/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 NPC1 1770/4885RAB9A 3507/4885KLF5 3498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.